Travelgrant 2024, Korea, BIOKOREA, 8-10 may 2024
| Reference number | |
| Coordinator | Pelago Bioscience AB |
| Funding from Vinnova | SEK 16 500 |
| Project duration | May 2024 - May 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
Important results from the project
** Denna text är maskinöversatt ** Participation in BioKorea 2024 has been very rewarding and has met our expectations by giving us a deeper insight into the Korean biotech market and by establishing new, potentially lucrative customer contacts. We will continue to build on these relationships and explore new business opportunities in Korea.
Expected long term effects
** Denna text är maskinöversatt ** 1. Visit to Samsung Biologics in Songdo, Incheon, which provided valuable insight into a leading player in the Korean biopharma sector. 2.Participation in a Master class on the biotech market in Korea, which deepened our understanding of market dynamics 3. Partnering meetings at Biokorea, where we had the opportunity to network and discuss potential collaborations with other companies and researchers. 4 Presentation by Pelago Bioscience, which gave us the opportunity to showcase our company and the services we offer to an international audience.
Approach and implementation
** Denna text är maskinöversatt ** The trip to South Korea took place in May from May 4 -11. Den Svensk Danish biopharma delegation took place 7-10 May with participation at Biokorea on 8-10 May 2024.